RTW Investments’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.86M | Buy |
+3,461,500
| New | +$7.86M | 0.11% | 62 |
|
|
2024
Q3 | – | Sell |
-1,200,002
| Closed | -$1.46M | – | 70 |
|
|
2024
Q2 | $1.46M | Buy |
+1,200,002
| New | +$1.46M | 0.02% | 66 |
|
|
2022
Q3 | – | Sell |
-2,849,707
| Closed | -$5.22M | – | 91 |
|
|
2022
Q2 | $5.22M | Sell |
2,849,707
-2,929,993
| -51% | -$5.36M | 0.13% | 77 |
|
|
2022
Q1 | $15.4M | Sell |
5,779,700
-250,000
| -4% | -$668K | 0.32% | 59 |
|
|
2021
Q4 | $26.1M | Buy |
6,029,700
+4,628,761
| +330% | +$20M | 0.38% | 58 |
|
|
2021
Q3 | $7.13M | Hold |
1,400,939
| – | – | 0.11% | 85 |
|
|
2021
Q2 | $8.87M | Sell |
1,400,939
-132,819
| -9% | -$841K | 0.13% | 77 |
|
|
2021
Q1 | $11.9M | Buy |
1,533,758
+6,406
| +0.4% | +$49.5K | 0.19% | 67 |
|
|
2020
Q4 | $10M | Buy |
1,527,352
+1,349
| +0.1% | +$8.84K | 0.17% | 69 |
|
|
2020
Q3 | $10.1M | Buy |
1,526,003
+11,527
| +0.8% | +$76.7K | 0.24% | 63 |
|
|
2020
Q2 | $12.6M | Buy |
1,514,476
+447,685
| +42% | +$3.73M | 0.35% | 50 |
|
|
2020
Q1 | $8.18M | Buy |
1,066,791
+27,198
| +3% | +$209K | 0.35% | 47 |
|
|
2019
Q4 | $8.64M | Buy |
1,039,593
+49,130
| +5% | +$408K | 0.33% | 52 |
|
|
2019
Q3 | $7.31M | Buy |
990,463
+2,144
| +0.2% | +$15.8K | 0.43% | 45 |
|
|
2019
Q2 | $11.1M | Buy |
988,319
+23,067
| +2% | +$259K | 0.59% | 36 |
|
|
2019
Q1 | $10.4M | Buy |
965,252
+56,666
| +6% | +$609K | 0.71% | 32 |
|
|
2018
Q4 | $13.7M | Buy |
+908,586
| New | +$13.7M | 1.26% | 25 |
|